Available drugs and supplements for rapid deployment for treatment of COVID-19

• 作者: Danielle Cicka Vikas P.Sukhatme
• 来源期刊: 分子细胞生物学报（英文版）
• 年，卷（期）: 2021,（3）
• 所属期刊栏目: Perspective
• 页码范围: 232-236
• 页数: 5页
• 语种: 英文
• DOI: 10.1093/jmcb/mjab002

摘要

Effective treatment for COVID-19 remains elusive,though urgently needed in the current pandemic.Repurposing marketed therapies may be an effective strategy for finding treatments quickly and recently,in vitro and clinical testing of such therapies against severe acute respi-ratory syndrome coronavirus 2(SARS-CoV-2)has skyrocketed.However,not all mar-keted drugs showing in vitro efficacy could achieve therapeutic concentrations in humans and discernment of drugs that have favorable pharmacokinetic proper-ties can save time and resources for fu-ture studies.